Understanding the biology and use of TNF therapy in jia-clinical outcomes

Lignende værker

• Understanding the biology and use of anti-TNF agents in JIA – interim results
  af: Lovell, Daniel J, et al.
  Udgivet: (2012)
• High levels of DEK autoantibodies may predict early flare following cessation of anti-TNF therapy in juvenile idiopathic arthritis
  af: Mor-Vaknin, Nirit, et al.
  Udgivet: (2014)
• High Levels of DEK Autoantibodies in Sera of Patients With Polyarticular Juvenile Idiopathic Arthritis and With Early Disease Flares Following Cessation of Anti–Tumor Necrosis Factor Therapy
  af: Mor‐Vaknin, Nirit, et al.
  Udgivet: (2018)
• Risk, Timing and Predictors of Disease Flare after Discontinuation of Anti-Tumor Necrosis Factor (TNF) Therapy in Children with Polyarticular Forms of Juvenile Idiopathic Arthritis (JIA) in Clinical Inactive Disease
  af: Lovell, Daniel J., et al.
  Udgivet: (2018)
• Trajectories of disease courses in the inception cohort of newly diagnosed patients with JIA (ICON-JIA): the potential of serum biomarkers at baseline
  af: Ganeva, Margarita, et al.
  Udgivet: (2021)